The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
Abstract
The annual mortality from cardiovascular disease in dialysis patients is substantially higher than in the general population (Figure 1) (1). The 5-yr survival of men >64 yr old starting dialysis is worse than that of men with colon cancer and prostate cancer (2). The 5-yr survival of women >64 yr old starting dialysis is worse than that of women with breast cancer and colon cancer (2). About half the deaths in dialysis patients are attributed to cardiovascular disease (2). Hospitalizations of dialysis patients occur frequently and about one-third are the result of cardiovascular disease (2). Despite enormous morbidity and premature mortality resulting from cardiovascular disease, it is only recently that the clinical epidemiology of cardiovascular disease in chronic renal failure has become a major focus of nephrology research.Figure 1: Cardiovascular disease mortality by age, race, and gender in the general population and in dialysis patients. Cardiovascular mortality is defined as death due to arrhythmias, cardiomyopathy, cardiac arrest, myocardial infarction, atherosclerotic heart disease, and pulmonary edema. Data from the general population are from the National Center for Health Statistics multiple cause of mortality files 1993. Data from dialysis patients include hemodialysis and peritoneal dialysis combined from USRDS 1994-1996. Reprinted with permission from Am J Kidney Dis 32[Suppl 3]: S115, 1998.A task force convened by the National Kidney Foundation has considered whether strategies for prevention and treatment of cardiovascular disease in the general population are applicable in patients with chronic renal disease. Two target conditions (coronary artery disease and left ventricular hypertrophy) and four target populations (chronic renal insufficiency, hemodialysis, peritoneal dialysis, and renal transplantation) were considered. Detailed reports are available in a supplement of the American Journal of Kidney Diseases (3). The major focus was on traditional cardiac risk factors identified in the general population, including hyperlipidemia, hypertension, diabetes mellitus, tobacco use, menopause, and physical inactivity. In addition, a recent volume of Seminars in Dialysis was devoted to consideration of potential uremia-related risk factors (4). These included risk factors altered by the uremic state, such as dyslipidemia, prothrombotic factors, hyperhomocysteinemia, and also risk factors characteristic of chronic uremia, such as hemodynamic overload, anemia, increased oxidant stress, hypoalbuminemia, and divalent ion abnormalities (Table 1).Table 1: Cardiac risk factors in chronic uremiaPathogenesis of Cardiac Disease Manifestations of ischemic heart disease, such as angina pectoris or myocardial infarction, are caused by disorders of coronary vessel perfusion. Ischemic heart disease is usually the result of critical coronary artery disease, but in 27% of hemodialysis patients ischemic symptoms are caused by nonatherosclerotic disease (5) (Figure 2). The latter is associated with the underlying cardiomyopathy, small vessel disease (caused by hypertension, diabetes mellitus, and calcium phosphate deposition), reduced capillary density, and abnormal myocyte bioenergetics (6). Left ventricular (LV) hypertrophy predisposes to ischemic symptoms by reducing coronary reserve.Figure 2: Cardiomyopathy and ischemic heart disease in chronic uremia.Heart failure is the most common symptom of an underlying cardiomyopathy (Figure 2). LV structure and function alters as a result of LV pressure and volume overload, and of myocyte death (6) (Figure 3). LV pressure overload results from hypertension, arteriosclerosis, and occasionally aortic stenosis. It causes concentric LV hypertrophy, with increased myocyte thickness and little change in LV volume. LV volume overload results from salt and water overload, anemia, and the arteriovenous fistula. It causes eccentric LV hypertrophy, with increase in myocyte length and increase in LV volume. Initially, the LV hypertrophy is adaptive in both types of overload, and is beneficial because energy is spared by maintaining stable wall stress. However, the LV hypertrophy eventually becomes maladaptive, and is harmful because of myocyte death (resulting from continuing LV overload), decrease in capillary density, increase in myocardial fibrosis, diastolic dysfunction, and LV conduction abnormalities. The LV volume-LV pressure curve is displaced to the left, and altered in such a manner that small changes in LV volume result in large changes in LV pressure, predisposing to symptomatic LV failure (6).Figure 3: Left ventricular (LV) pressure overload, LV volume overload, and myocyte death in chronic uremia.Myocyte death induces LV dilation with compensatory LV hypertrophy. Eventually, systolic dysfunction occurs. In addition to continuing LV overload, myocyte death may be caused by decreased large and small coronary vessel perfusion, hyperparathyroidism, malnutrition, and oth
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Self-citation(1996) · Transplantation · doi:10.1097/00007890-199604150-00008 · Cited by 1,055
Levey, A., Beto, J., Coronado, B., Eknoyan, G., Foley, R., Kasiske, B., Klag, M., Mailloux, L., Manske, C., Meyer, K., et al. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70145-3 · Cited by 946
Self-citationPoor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis
Herzog, C. A., Ma, J. Z., & Collins, A. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391203 · Cited by 885
Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
Levin, A., Thompson, C. R., Ethier, J., Carlisle, E. J. F., Tobe, S., Mendelssohn, D., Burgess, E., Jindal, K., Barrett, B., Singer, J., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70118-6 · Cited by 841
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Self-citationCongestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
Harnett, J. D., Foley, R. N., Kent, G. M., Barre, P. E., Murray, D., & Parfrey, P. S. (1995) · Kidney International · doi:10.1038/ki.1995.132 · Cited by 719
Self-citationLevin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Report on Management of Renal Failure in Europe, XXIV, 1993
Valderrabano, F., Jones, E. H. P., & Mallick, N. P. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp5.1 · Cited by 699
Cardiovascular disease after renal transplantation.
Kasiske, B. L., Guijarro, C., Massy, Z. A., Wiederkehr, M. R., & Ma, J. Z. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v71158 · Cited by 669
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Nohria, A., Hasselblad, V., Stebbins, A., Pauly, D. F., Fonarow, G. C., Shah, M., Yancy, C. W., Califf, R. M., Stevenson, L. W., & Hill, J. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.072 · Cited by 592
Metadata
- Authors
- PARFREY, P. S., & FOLEY, R. N.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1999-07
- Volume
- 10
- Issue
- 7
- Pages
- 1606-1615
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2169896560
- Cited by
- 653
- References
- 41
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure. https://app.cochat.ai/papers/10.1681/asn.v1071606
- The paper
- PARFREY, P. S., & FOLEY, R. N. (1999). The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v1071606
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.